866-997-4948(US-Canada Toll Free)

Migraine Therapeutics - Pipeline Assessment and Market Forecasts to 2016

Published By :

GlobalData

Published Date : Jul 2010

Category :

Therapeutic Area

No. of Pages : 48 Pages


GlobalData, the industry analysis specialists new report, Migraine Pipeline Assessment and Market Forecasts to 2016 is an essential source of information and analysis on the global migraine market. The report identifies the key trends shaping and driving the global migraine market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global migraine sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts.

Scope

The report provides information on the key driver and challenges of the global migraine market. Its scope includes:

  • Annualized global migraine market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include 5-HT1D agonist, 5-HT1 agonist, AMPA/kainate receptor antagonist, Neuro transmitter system receptor, bacterial Neurotoxin (muscle relaxant), 5-HT targetor, calcitonin gene related peptide (CGRP) targetors, GABA transaminase inhibitors, nitric oxide inhibitors, prostaglandin synthesis inhibitor, opioid receptor agonist, antiemetic and gastroprokinetic agents, anti-inflammatory and immunosuppressant, and cyclooxygenase-2 (COX-2) inhibitors.
  • Analysis of the current and future market competition in the global migraine market. Key market players covered are GlaxoSmithKline, Eli Lilly and Company, Merck & Co., Inc., Pozen, Inc., Eisai Co., Ltd., Johnson & Johnson, Inc., NuPathe Inc., and Abbott Laboratories.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with migraine therapeutics.

Reasons to buy

The report will enhance your decision making capability in a rapid and time sensitive manner. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global migraine market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global migraine market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • Whats the next big thing in the global migraine market landscape? Identify, understand and capitalize.
Table Of Contents

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5

2 Migraine Therapeutics: Market Characterization 6
2.1 Market Overview 6
2.2 Overview on Accessibility of Various Migraine Treatments in the Market 6
2.3 Migraine Market Size 6
2.4 Migraine Market Forecast and CAGR 7
2.5 Drivers and Barriers for the Migraine Market 8
2.5.1 Drivers for the Migraine Market 8
2.5.2 Barriers for the Migraine Market 9
2.6 Opportunity and Unmet Need 9
2.7 Key Takeaway 11

3 Migraine Therapeutics: Competitive Assessment 12
3.1 Overview 12
3.2 Strategic Competitor Assessment 12
3.3 Product Profile for the Major Marketed Products in Migraine Market 13
3.3.1 ZOMIG (ZOMIG, ZOMIG-ZMT) 13
3.4 Maxalt 14
3.4.2 Frova 16
3.4.3 Relpax 16
3.4.4 Axert/Almogran 17
3.4.5 Amerge 18
3.5 Key Takeaway 21

4 Migraine Therapeutics: Pipeline Assessment 22
4.1 Overview 22
4.2 Strategic Pipeline Assessment 22
4.2.1 Technology Trends Analytic Framework 22
4.3 Migraine Therapeutics Promising Drugs under Clinical Development 24
4.4 Molecule Profile for Promising Drugs under Clinical Development 24
4.4.1 Lasmiditan (COL-144; LY573144) 24
4.4.2 BOTOX 25
4.4.3 Tezampanel 26
4.4.4 Telcagepant 26
4.5 Migraine Therapeutic Market Clinical Pipeline by Mechanism of Action 27
4.6 Migraine Pipeline Pipeline by Clinical Phases of Development 28
4.6.1 Migraine Therapeutics Phase III Clinical Pipeline 29
4.6.2 Migraine Therapeutics Phase II Clinical Pipeline 30
4.6.3 Migraine Therapeutics Phase I Clinical Pipeline 31
4.6.4 Migraine Therapeutics Preclinical Pipeline 31
4.6.5 Migraine Therapeutics Discovery Pipeline 32
4.7 Discontinued/ Suspended Drugs for Migraine 33
4.8 Key Takeaway 34

5 Migraine Therapeutics: Implications for Future Market Competition 35

6 Migraine Therapeutics: Future Players in the Migraine Market 37
6.1 Introduction 37
6.2 CoLucid Pharmaceuticals, Inc. 37
6.2.1 Company Overview 37
6.2.2 Major Products & Services 38
6.2.3 CNS Pipeline Overview 38
6.3 GlaxoSmithKline 38
6.3.1 Company Overview 38
6.3.2 Business Description 38
6.3.3 CNS Pipeline Overview 39
6.4 Eli Lilly and Company 39
6.4.1 Company Overview 39
6.4.2 Business Description 39
6.4.3 CNS Pipeline Overview 40
6.5 Merck & Co Inc 40
6.5.1 Company Overview 40
6.5.2 Business Description 40
6.5.3 CNS Pipeline Overview 41
6.6 POZEN Inc. 41
6.6.1 Overview 41
6.6.2 Business Description 41
6.6.3 CNS Pipeline Overview 42

7 Migraine Therapeutics: Appendix 43
7.1 Definitions 43
7.2 Abbreviations 43
7.3 Research Methodology 44
7.3.1 Coverage 44
7.3.2 Secondary Research 44
7.3.3 Forecasting 44
7.3.4 Primary Research 47
7.3.5 Expert Panel Validation 47
7.4 Contact Us 47
7.5 Disclaimer 47
7.6 Sources 48

List of Table


Table 1: Migraine Therapeutics, Global, Market Revenue, 20012009 7
Table 2: Migraine Therapeutics, Global, Market Forecast, 20092016 8
Table 3: Major Marketed Products Analysis in Migraine Market, 2010 20
Table 4: Migraine Therapeutics Most Promising Drugs Under Clinical Development, 2010 24
Table 5: Migraine Therapeutics Phase III Clinical Pipeline, 2010 29
Table 6: Migraine Therapeutics Phase II Clinical Pipeline, 2010 30
Table 7: Migraine Therapeutics Phase I Clinical Pipeline, 2010 31
Table 8: Migraine Therapeutics Preclinical Pipeline, 2010 31
Table 9: Migraine Therapeutics Discovery Pipeline, 2010 32
Table 10: List of Discontinued/Suspended Drugs for Migraine, 2010 33
Table 11: CoLucid Pharmaceuticals CNS Pipeline, 2010 38
Table 12: GlaxoSmithKline CNS Pipeline, 2010 39
Table 13: Eli Lilly & Company CNS Pipeline, 2010 40
Table 14: Merck & Co Inc CNS Pipeline, 2010 41
Table 15: Pozen Inc CNS Pipeline, 2010 42

List of Chart


Figure 1: Migraine Therapeutics, Global, Market Revenue, 20012009 7
Figure 2: Migraine Therapeutics, Global, Market Forecast, 20092016 8
Figure 3: Opportunity and Unmet Need in the Migraine Market, 2010 10
Figure 4: Strategic Competitor Assessment of the Marketed Products for Migraine, 2010 13
Figure 5: Technology Trends Analytic Framework of the Migraine Pipeline, 2010 22
Figure 6: Technology Trends Analytic Framework of the Migraine Pipeline Description, 2010 23
Figure 7: Migraine Therapeutics Market Clinical Pipeline by Mechanism of Action, 2010 27
Figure 8: Migraine Pipeline by Phase of Clinical Development, 2010 28
Figure 9: Implications for Future Market Competition in Migraine Market, 2010 35
Figure 10: Migraine Therapeutics Market Clinical Pipeline by Company, 2010 37
Figure 11: GlobalData Market Forecasting Model 46

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *